This year, we will have the pleasure to welcome Dr Bernhard Hube, from Leibniz-Hans Knöll Institute in Germany. Dr Hube will present his work on “The commensal-to-pathogen shift of Candida albicans”.
Bernhard Hube earned his PhD in Microbiology at the University of Goettingen (1991) and spent his postdoctoral time at the University of Aberdeen (1992 – 1995) and the University of Hamburg (1995 – 2000). In 2000 he became Research Group leader and Head of Division “Mycology”, at the Robert Koch Institute, Berlin. In 2006 he was appointed Professor and Chair for Microbial Pathogenicity at the Friedrich Schiller University of Jena, and in 2007 Head of the Department of Microbial Pathogenicity Mechanisms at the Leibniz-HKI in Jena, Germany. He has co-authored > 300 publications dealing with the molecular and infection biology of human pathogenic fungi, in particular Candida species. He discovered one of the first virulence genes, encoding a secreted aspartic proteinase, in C. albicans. His recent research focuses on the first peptide toxin discovered in human pathogenic fungi, candidalysin.
Discover the work of the Labex IBEID partners through the scientific oral presentations.
